Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
Caiqin Xie, Xian Li, Hui Zeng, et al.
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials
Yang Xu, Ping Li, Yang Liu, et al.
Cancer Communications (2022) Vol. 42, Iss. 6, pp. 493-516
Open Access | Times Cited: 24
Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas
Sang Eun Yoon, Junhun Cho, Yeon Jeong Kim, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 30
Genetic Landscape of Peripheral T-Cell Lymphoma
Vivian Hathuc, Friederike Kreisel
Life (2022) Vol. 12, Iss. 3, pp. 410-410
Open Access | Times Cited: 19
Differential diagnosis and identification of prognostic markers for peripheral T-cell lymphoma subtypes based on flow cytometry immunophenotype profiles
Qiyao Pu, Jie Qiao, Yuke Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
三例复合性B细胞和T细胞淋巴瘤患者的临床、 病理和分子学特征的分析及文献回顾
Xueli Jin, Hui Liu, Jing Li, et al.
Journal of Zhejiang University SCIENCE B (2023) Vol. 24, Iss. 8, pp. 711-722
Open Access | Times Cited: 8
Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma
Jing Chen, Jie Zhou, Fei Cheng, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 2
Novel agents and regimens in relapsed or refractory peripheral T-cell lymphoma: latest updates from 2023 ASH annual meeting
Huageng Huang, Wei Zhang, Xinyi Deng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Histone Deacetylase Inhibitors for Peripheral T-Cell Lymphomas
Ruxandra Irimia, Pier Paolo Piccaluga
Cancers (2024) Vol. 16, Iss. 19, pp. 3359-3359
Open Access | Times Cited: 2
Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Seok Jin Kim, Yeon Jeong Kim, Sang Eun Yoon, et al.
Cancer Research and Treatment (2022) Vol. 55, Iss. 1, pp. 291-303
Open Access | Times Cited: 10
Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches
Yuran Qiu, Weili Zhao
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100048-100048
Open Access | Times Cited: 1
TP53 and KMT2D mutations associated with worse prognosis in peripheral T‐cell lymphomas
Lingling Wang, Lei Yang, Fangshu Guan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 1
Histone Deacetylase Inhibitors for Peripheral T-cell Lymphomas: From Biology to Real-World Therapy
Ruxandra Irimia, Pier Paolo Piccaluga
(2024)
Open Access | Times Cited: 1
A nodal EBV‐positive T cell lymphoma with a T follicular helper cell phenotype
Zhaoxuan Zhang, Wei Wang, Yuan Li, et al.
Histopathology (2023) Vol. 83, Iss. 1, pp. 137-142
Closed Access | Times Cited: 3
Characteristics of genetic alterations of peripheral T‐cell lymphoma in childhood including identification of novel fusion genes: the Japan Children’s Cancer Group (JCCG)
Kentaro Ohki, Nobutaka Kiyokawa, Satoru Watanabe, et al.
British Journal of Haematology (2021) Vol. 194, Iss. 4, pp. 718-729
Open Access | Times Cited: 7
Misdiagnosis of angioimmunoblastic T‑cell lymphoma: A case report
Yan Li, Xiaohan Gao, Ling-Zhijie Kong, et al.
Oncology Letters (2023) Vol. 25, Iss. 6
Open Access | Times Cited: 1
Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches
Yuran Qiu, Weili Zhao
The Innovation Medicine (2024), pp. 100048-100048
Open Access
Pre-treatment [ 18 F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma
Jing Chen, Yi Zhao
Hematology (2024) Vol. 29, Iss. 1
Open Access
Advances in DNA Methylation in Peripheral T Cell Lymphoma
向慧 张
Advances in Clinical Medicine (2024) Vol. 14, Iss. 08, pp. 1181-1187
Closed Access
Sustained yet non-curative response to lenalidomide in relapsed angioimmunoblastic T-cell lymphoma with acquired chidamide resistance: a case report with 10-year follow-up, genetic insights and literature review
Juan Xu, Jie Huang, Liping Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Cytomorphological characterisation of angioimmunoblastic T cell lymphoma: a case–control study
Parikshaa Gupta, Nalini Gupta, Amanjit Bal, et al.
Journal of Clinical Pathology (2021) Vol. 76, Iss. 5, pp. 320-326
Closed Access | Times Cited: 3
Molecular Advances in Nodal Peripheral T-Cell Lymphoma
Safina Hafeez, Allison M. Cushman‐Vokoun
Advances in Molecular Pathology (2022) Vol. 5, Iss. 1, pp. 51-58
Closed Access | Times Cited: 1
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series
Pietro Torre, Annalisa Brescia, Giorgio Giurato, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2921-2921
Open Access
Angioimmunoblastic T-cell lymphoma combined with Hodgkin’s lymphoma:a case report
Xiaohan Gao, Jing Li, Lin Kang, et al.
Authorea (Authorea) (2021)
Open Access
Page 1

Scroll to top